Clinical Trial: Pharmacokinetics and Bioequivalence Study of Budesonide Inhalation Aerosol in Humans

U.S., April 12 -- ClinicalTrials.gov registry received information related to the study (NCT06924190) titled 'Pharmacokinetics and Bioequivalence Study of Budesonide Inhalation Aerosol in Humans' on March 29.

Brief Summary: The test formulation of Budesonide Inhalation Aerosol is bioequivalent to the reference formulation in healthy Chinese subjects under fasting conditions.

Study Start Date: Dec. 30, 2024

Study Type: INTERVENTIONAL

Condition: Bioequivalence Study in Healthy Subjects

Intervention: DRUG: Budiair(R) 200ug/puff inhalation aerosol

The subjects randomly received one puff Budiair(R)(budesonide inhalation aerosol 200ug/puff )

DRUG: budesonide 200ug/puff inhalation aerosol

The subjects randomly received one puff budesonid...